References
- DegenhardtLHallWWarner-SmithMUsing cohort studies to estimate mortality among injecting drug users that is not attributable to AIDSSex Transm Infect200682Suppl 3iii56iii6316735295
- StrasselsSAEconomic burden of prescription opioid misuse and abuseJ Manag Care Pharm200915755656219739878
- YokellMAZallerNDGreenTCRichJDBuprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international reviewCurr Drug Abuse Rev201141284121466501
- TzatzarakisMNVakonakiEKovatsiLDetermination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapyJ Anal Toxicol201539431332025663675
- BelivanisSTzatzarakisMNVakonakiEBuprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatmentDrug Test Anal20146Suppl 19310024817054
- GerraGFantomaAZaimovicANaltrexone and buprenorphine combination in the treatment of opioid dependenceJ Psychopharmacol200620680681416401652
- United States National Institutes of Health. National Institute on Drug Abuse (NIH/NIDA)Buprenorphine: an alternative treatment for opioid dependenceBlaineJNIDA Research Monograph Series1992 Available from: https://archives.drugabuse.gov/sites/default/files/monograph121.pdfAccessed November 05, 2018
- SigmonSCMoodyDENuwayserESBigelowGEAn injection depot formulation of buprenorphine: extended bio-delivery and effectsAddiction2006101342043216499515
- BaumevieilleMHaramburuFBégaudBAbuse of prescription medicines in southwestern FranceAnn Pharmacother1997317–88478509220042
- TothCDrug safety evaluation of pregabalinExpert Opin Drug Saf201211348750222468635
- SchifanoFMisuse and abuse of pregabalin and gabapentin: cause for concern?CNS Drugs201428649149624760436
- AuriacombeMFatséasMDubernetJDaulouèdeJPTignolJFrench field experience with buprenorphineAm J Addict200413Suppl 1S17S2815204673
- MoattiJPVlahovDFeroniIPerrinVObadiaYOdabiaYMultiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, FranceEur Addict Res200171404511316925
- JonesJDManubayJMMogaliSAbuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amountDrug Alcohol Depend201717936236928844013
- FilipettoFAZippCPCorenJSPotential for pregabalin abuse or diversion after past drug-seeking behaviorJ Am Osteopath Assoc20101101060560721068226
- GrosshansMMutschlerJHermannDPregabalin abuse, dependence, and withdrawal: a case reportAm J Psychiatry2010167786920595436